PT Soho Global Health Tbk (IDX: SOHO)
Health Care · Pharmaceuticals · ID
Rp1,195.00
+1.70% today · +58.3% 1Y
PT Soho Global Health Tbk (IDX: SOHO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $859.25M and employs 2,328 people.
Over the last twelve months the share price has gained 58.3%, trading between 710.00 and 4.01K.
Tweenvest scores PT Soho Global Health Tbk across four factors: quality 68/100, value 40/100, dividend 79/100. Its strongest factor is dividend.
SOHO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $859.25M
- Revenue (TTM)
- $613.37M
- P/E
- 22.21
- EPS
- 53.81
- Dividend yield
- 6.61%
- Beta (5Y)
- 0.86
- 52-week high
- Rp4,010.00
- 52-week low
- Rp710.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.69B
- Employees
- 2,328
- Next earnings
- —
About PT Soho Global Health Tbk
PT Soho Global Health Tbk, together with its subsidiaires, operates as a healthcare company in Indonesia. It operates through Distributions, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and distribution and logistics services. It also offers body defense, stamina and vitality, brain nutrient, eye health, skin care, weight management, and wellness products; sells and markets medical devices and medical equipment products in the areas of wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics; and provides product registration, marketing intelligence, sales, and marketing support services. In addition, it provides contract manufacturing services for various dosage forms. The company was founded in 1946 and is headquartered in Jakarta, Indonesia.
- ISIN
- ID1000157506
- Founded
- 1946
- Listed since
- Sep 8, 2020
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.